273 related articles for article (PubMed ID: 21872576)
21. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
[TBL] [Abstract][Full Text] [Related]
22. Differential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous system.
Funahashi S; Hasegawa T; Nagano A; Sato K
J Comp Neurol; 2008 Jan; 506(1):141-60. PubMed ID: 17990276
[TBL] [Abstract][Full Text] [Related]
23. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
[TBL] [Abstract][Full Text] [Related]
24. Nogo receptor is involved in the adhesion of dendritic cells to myelin.
McDonald CL; Steinbach K; Kern F; Schweigreiter R; Martin R; Bandtlow CE; Reindl M
J Neuroinflammation; 2011 Sep; 8():113. PubMed ID: 21906273
[TBL] [Abstract][Full Text] [Related]
25. Effects of N-Butylphthalide on the expressions of Nogo/NgR in rat brain tissue after carbon monoxide poisoning.
Li Q; Cheng Y; Bi MJ; Kang H; Qu Y; Lin H; Guo Y; Zou Y
Environ Toxicol Pharmacol; 2015 Mar; 39(2):953-61. PubMed ID: 25812770
[TBL] [Abstract][Full Text] [Related]
26. Increased hippocampal NgR1 signaling machinery in aged rats with deficits of spatial cognition.
VanGuilder Starkey HD; Sonntag WE; Freeman WM
Eur J Neurosci; 2013 May; 37(10):1643-58. PubMed ID: 23438185
[TBL] [Abstract][Full Text] [Related]
27. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells.
Huang JY; Wang YX; Gu WL; Fu SL; Li Y; Huang LD; Zhao Z; Hang Q; Zhu HQ; Lu PH
Brain Res; 2012 Feb; 1437():1-15. PubMed ID: 22227458
[TBL] [Abstract][Full Text] [Related]
28. A multi-domain fragment of Nogo-A protein is a potent inhibitor of cortical axon regeneration via Nogo receptor 1.
Huebner EA; Kim BG; Duffy PJ; Brown RH; Strittmatter SM
J Biol Chem; 2011 May; 286(20):18026-36. PubMed ID: 21454605
[TBL] [Abstract][Full Text] [Related]
29. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells.
Mehta NR; Lopez PH; Vyas AA; Schnaar RL
J Biol Chem; 2007 Sep; 282(38):27875-86. PubMed ID: 17640868
[TBL] [Abstract][Full Text] [Related]
30. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
[TBL] [Abstract][Full Text] [Related]
31. Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonists.
Williams G; Wood A; Williams EJ; Gao Y; Mercado ML; Katz A; Joseph-McCarthy D; Bates B; Ling HP; Aulabaugh A; Zaccardi J; Xie Y; Pangalos MN; Walsh FS; Doherty P
J Biol Chem; 2008 Jun; 283(24):16641-52. PubMed ID: 18411262
[TBL] [Abstract][Full Text] [Related]
32. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory proteins against axon regeneration in the central nervous system].
Hu JG; Lu PH; Xu XM
Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
[TBL] [Abstract][Full Text] [Related]
34. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
[TBL] [Abstract][Full Text] [Related]
36. The Nogo receptor complex: confining molecules to molecular mechanisms.
Schwab JM; Tuli SK; Failli V
Trends Mol Med; 2006 Jul; 12(7):293-7. PubMed ID: 16723274
[TBL] [Abstract][Full Text] [Related]
37. Spatio-temporal expression pattern of receptors for myelin-associated inhibitors in the developing rat olfactory system.
Richard M; Sacquet J; Jourdan F; Pellier-Monnin V
Brain Res; 2009 Feb; 1252():52-65. PubMed ID: 19063867
[TBL] [Abstract][Full Text] [Related]
38. Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display.
Schimmele B; Plückthun A
J Mol Biol; 2005 Sep; 352(1):229-41. PubMed ID: 16061255
[TBL] [Abstract][Full Text] [Related]
39. Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.
Hånell A; Clausen F; Björk M; Jansson K; Philipson O; Nilsson LN; Hillered L; Weinreb PH; Lee D; McIntosh TK; Gimbel DA; Strittmatter SM; Marklund N
J Neurotrauma; 2010 Jul; 27(7):1297-309. PubMed ID: 20486800
[TBL] [Abstract][Full Text] [Related]
40. Nogo on the go.
McKerracher L; Winton MJ
Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
